
HER2+ Breast Cancer
Latest News
Advertisement
Latest Videos

CME Content
Advertisement
More News



Erika P. Hamilton, MD, discusses the evolution of treatment in HER2-positive breast cancer.

Trastuzumab emtansine has been approved in the UK for the adjuvant treatment of patients with HER2-positive early breast cancer.

Katherine D. Crew, MD, MS, discusses recent advances made in HER2-positive breast cancer treatment.

Sara M. Tolaney, MD, MPH, discusses sequencing strategies in metastatic HER2-positive breast cancer.

Anne Favret, MD, discusses the evolution of treatment in HER2-positive breast cancer.

Global access to neratinib has increased with the drug now being made commercially available in Singapore.

















Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
3
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5













































